Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elmar Jaeckel

Showing results (91-100 of 143) with videos related to

Pageof 15
Sort By:
Blood|November 11, 2010
PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cellsWolfgang Koestner, Martin Hapke, Jessica Herbst, et al.
Medicine|February 20, 2021
Evaluation of perfusion changes using a 2D Parametric Parenchymal Blood Flow technique with automated vessel suppression following partial spleen embolization in patients with hypersplenism and portal hypertensionTimo C Meine, Sabine K Maschke, Martha M Kirstein, et al.
Journal of Hepatology|May 30, 2025
Personalized survival benefit estimation from living donor liver transplantation with a novel machine learning method for confounding adjustmentAnirudh Gangadhar, Bima J Hasjim, Xun Zhao, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 28, 2023
Should advanced donor age be a deterrent in the utilization of grafts from donation after cardiac death in deceased donor liver transplantation? The Toronto experienceSamrat Ray, Chaya Shwaartz, Blayne Amir Sayed, et al.
Plos One|June 9, 2017
Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitisRichard Taubert, Matthias Hardtke-Wolenski, Fatih Noyan, et al.
Journal of Autoimmunity|June 10, 2019
Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetesMichel Tenspolde, Katharina Zimmermann, Leonie C Weber, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 29, 2023
Outcomes of re-referrals of patients with alcohol-associated liver disease, who were previously declined for liver transplantationBen Cox, Lauren Carrique, Tommaso Di Maira, et al.
Molecular Pharmaceutics|August 20, 2011
Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapyInés Avedillo Díez, Daniela Zychlinski, Emanuele G Coci, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 20, 2023
Unique 40-year survival after heart transplantation with normal graft function and spontaneous operational toleranceWolfgang von Scheidt, Bruno Reichart, Bruno Meiser, et al.
Hepatology (Baltimore, Md.)|December 6, 2014
Autoimmune hepatitis in a murine autoimmune polyendocrine syndrome type 1 model is directed against multiple autoantigensMatthias Hardtke-Wolenski, Richard Taubert, Fatih Noyan, et al.
Pageof 15

Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
Blood|November 11, 2010
PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cellsWolfgang Koestner, Martin Hapke, Jessica Herbst, et al.
Medicine|February 20, 2021
Evaluation of perfusion changes using a 2D Parametric Parenchymal Blood Flow technique with automated vessel suppression following partial spleen embolization in patients with hypersplenism and portal hypertensionTimo C Meine, Sabine K Maschke, Martha M Kirstein, et al.
Journal of Hepatology|May 30, 2025
Personalized survival benefit estimation from living donor liver transplantation with a novel machine learning method for confounding adjustmentAnirudh Gangadhar, Bima J Hasjim, Xun Zhao, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 28, 2023
Should advanced donor age be a deterrent in the utilization of grafts from donation after cardiac death in deceased donor liver transplantation? The Toronto experienceSamrat Ray, Chaya Shwaartz, Blayne Amir Sayed, et al.
Plos One|June 9, 2017
Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitisRichard Taubert, Matthias Hardtke-Wolenski, Fatih Noyan, et al.
Journal of Autoimmunity|June 10, 2019
Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetesMichel Tenspolde, Katharina Zimmermann, Leonie C Weber, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 29, 2023
Outcomes of re-referrals of patients with alcohol-associated liver disease, who were previously declined for liver transplantationBen Cox, Lauren Carrique, Tommaso Di Maira, et al.
Molecular Pharmaceutics|August 20, 2011
Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapyInés Avedillo Díez, Daniela Zychlinski, Emanuele G Coci, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 20, 2023
Unique 40-year survival after heart transplantation with normal graft function and spontaneous operational toleranceWolfgang von Scheidt, Bruno Reichart, Bruno Meiser, et al.
Hepatology (Baltimore, Md.)|December 6, 2014
Autoimmune hepatitis in a murine autoimmune polyendocrine syndrome type 1 model is directed against multiple autoantigensMatthias Hardtke-Wolenski, Richard Taubert, Fatih Noyan, et al.
Pageof 15